期刊档案 · 医学-药学
Journal of the American Pharmacists Association
ISSN 1544-3191 · eISSN 1544-3450 · American Pharmacists Association · UNITED STATES · Bimonthly · 创刊 2003
Journal of the American Pharmacists Association 中科院 医学 4区（2025 年升级版），影响因子 2.33，混合开放获取，APC 约 3,230 美元，近 24 个月 107 篇文章投稿到接收中位 101 天，录用比例容易（社区反馈），2025 年发文 609 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Journal of the American Pharmacists Association 由 American Pharmacists Association 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Pharmaceutical Practices and Patient Outcomes、Medication Adherence and Compliance、Opioid Use Disorder Treatment 等主题的论文，这 3 个主题约占 49.5%。（根据 OpenAlex 主题统计与中科院分区数据生成）
The mission of the Journal of the American Pharmacists Association (JAPhA) is to connect science and practice by publishing high-quality empirical studies, reviews on important healthcare topics, and thoughtful opinion pieces with the ultimate goal of optimizing medication use to improve patient and population health outcomes. We seek submissions that address efforts to advance pharmacy practice in any setting where a pharmacist may practice, optimize medication use, improve pharmacotherapy, and promote public health across the globe. Below is a non-exhaustive list of topics that are of potential interest to JAPhA:• Development and evaluation of innovative pharmacy services or models of care• Medication use studies• Interventions to improve medication use• Pharmacotherapeutic advances (especially as reviews)• Health outcomes research• Pharmacoepidemiology• Pharmacoeconomics• Health services research• Evaluations of drug benefit designs • Development and evaluation of healthcare policy • Implementation science• Patient reported outcomes and patient preferences• Education of pharmacists and pharmacy technicians, including continuing professional development• Issues affecting pharmacy as a profession (workforce issues, well-being, reimbursement, etc.)• Development and application of new technologies in healthcare• Development of research methods with applicability to pharmacy practice• Advocacy, legal, and regulatory issues related to pharmacy or healthcare.Submissions describing pharmacokinetic or pharmacodynamic studies without a direct link to applications in practice, animal models, or in vitro or in silico drug studies will not be considered. Although JAPhA will consider educational scholarship, submissions limited to the professional pharmacy curriculum are not generally considered unless there is a clear link to pharmacy practice. These guidelines serve to maintain and improve the quality of JAPhA. Questions regarding these guidelines or inquiries can be directed to the JAPhA Managing Editor, Mickie Cathers, at mcathers@aphanet.org.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-药学
主编 Pamela Heaton出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 39、加拿大 3、约旦 1（共 43 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Pharmaceutical Practices and Patient OutcomesMedicine29.5%
- Medication Adherence and ComplianceMedicine15.2%
- Opioid Use Disorder TreatmentMedicine4.8%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.7%
- Pharmaceutical studies and practicesMedicine3.5%
- Vaccine Coverage and HesitancySocial Sciences3.2%
- Antibiotic Use and ResistanceImmunology and Microbiology3.2%
- HIV, Drug Use, Sexual RiskMedicine2.6%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 药学PHARMACOLOGY & PHARMACY | 3 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 药学PHARMACOLOGY & PHARMACY | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 药学PHARMACOLOGY & PHARMACY | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 2.33LetPub ·
- 影响因子（出版商公布）
- 2.4出版商官网 ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore（出版商公布）
- 4出版商官网 ·
- SJR 2026-06
- 0.81LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 58LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 1,375OpenAlex ·
- 两年平均被引
- 0.75OpenAlex ·
- 自引率
- 12.5%LetPub ·
- Gold OA 文章占比
- 8.27%LetPub ·
发文规模
- 年文章数
- 175LetPub ·
逐年发文量 OpenAlex 统计 · 累计 5,290 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 498 | 51 | 39 |
| 2025 | 609 | 89 | 220 |
| 2024 | 290 | 130 | 787 |
| 2023 | 257 | 80 | 1,655 |
| 2022 | 307 | 129 | 2,684 |
| 2021 | 345 | 112 | 3,025 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
101 天投稿到接收中位数 · P25–P75 77 天 – 147 天
- 接收到上线
- 中位数 7 天（107 篇）
- 投稿到上线
- 中位数 113 天
- 样本
- 107 篇有投稿与接收日期的文章（窗口内共 487 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 较慢,6-12周LetPub ·
- 平均录用比例（社区反馈）
- 容易LetPub ·
- 投稿到首次决定
- 7 天出版商官网 ·
- 外审后首次决定
- 56 天出版商官网 ·
- 投稿到接收
- 99 天出版商官网 ·
- 接收到发表
- 7 天出版商官网 ·
- 评审方式
- 开放同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 3,230 / EUR 3,020 / GBP 2,590 / JPY 400,620 | — | — | |
| 出版商官网 | USD 3,560 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点2 项，摘自作者指南
- 摘要
- ≤ 300 词
- 参考文献格式
- AMA 格式
接收的文章类型12 种，含篇幅限制
- advances in pharmacy practiceAdvances in Pharmacy Practice Innovations or other related advances in pharmacy practice.未说明篇幅
- brief reportConcise but complete accounts of preliminary or focused original research or practice advances. Compared to "full" Research articles, a Brief Report is narrower…正文 ≤ 2,500 词
- brief reportsBrief Reports Concise but complete accounts of preliminary or focused original research or practice advances.未说明篇幅
- case reportOriginal, detailed reports of an individual or small number of patients, typically related to an adverse event. Case reports must include a description of the c…未说明篇幅
- case reportsCase Reports Original, detailed reports of an individual or small number of patients, typically related to an adverse event.未说明篇幅
- commentaryInformed (supported by referenced citations) personal opinions about events, trends, and/or developments in pharmacy or health care. The inclusion of new data s…未说明篇幅
- dose of inspirationDose of Inspiration未说明篇幅
- letterForum for readers to clarify, critique, challenge, or expand on material recently published in JAPhA. Letters must be received within 3 months of publication of…未说明篇幅
- lettersLetters未说明篇幅
- researchResearch Studies using well-developed methods to answer clearly stated research questions or hypotheses.未说明篇幅
- reviewReviews of topics relevant to pharmacy research and practice. These may include 2 general approaches:Structured reviews use a documented, reproducible, rigorous…未说明篇幅
- reviewsReviews Reviews of topics relevant to pharmacy research and practice.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、预印本、试验注册 / 报告规范
- AI 使用 Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Author contributions
For transparency, all articles should include an Author Contributions section on the title page outlining individual authors' contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draf…
原文 ↗出版商官网 ·- 利益冲突 Disclosure of conflicts of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in 2 places:A …
原文 ↗出版商官网 ·- 数据可用性
Data availability statement requested in acknowledgements; data sharing encouraged. 模型摘要
To foster transparency, we ask that you state the availability of your data as part of the acknowledgement section of your submission and encourage you to share your data with other scientists.
原文 ↗出版商官网 ·- 出版伦理
IRB approval or exemption statement required for human participants research. 模型摘要
Articles involving human participants are required to state within the article text as well as in the cover letter that approval or exemption has been granted by an institutional review board (IRB) or similar body.
原文 ↗出版商官网 ·- 许可与版权
Authors must obtain written permission for copyrighted excerpts. 模型摘要
If excerpts from other copyrighted works are included in submitted manuscripts, authors must obtain written permission from the copyright owners and credit the source(s) in the article.
原文 ↗出版商官网 ·- 开放获取 Open access
Funder open access agreements available. 模型摘要
Please visit our Open Access page for more information about open access publishing in this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
Partially open peer review: author identities disclosed, reviewer identities masked. 模型摘要
All manuscripts are initially screened by the editor and associate editors in a staff review process to determine fit with JAPhA's overall scope, scientific merit, and relevance to the field. Authors of manuscripts not selected for peer review are generally notified of this decision within 2 weeks after submission.JAPhA uses a partially open peer-review process in which the identities of authors a…
原文 ↗出版商官网 ·- 预印本 Preprint references
Preprints may be referenced; formal publication preferred when available. 模型摘要
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Reporting guidelines
reporting In the interest of improved clarity and quality of reporting, JAPhA requires authors to follow reporting guidelines and/or recommendations when preparing their manuscripts. Selected reporting guidelines are provided here. In some cases, the guidelines are accompanied by a checklist. These checklists act as a reminder for authors and an aid to the editors and peer reviewers when evaluatin…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- American Pharmacists Association
- 出版国家或地区
- UNITED STATES
- 出版语言
- English
- 出版周期
- Bimonthly
- 创刊年份
- 2003
- ISSN
- 1544-3191
- 电子版 ISSN
- 1544-3450
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Journal of the American Pharmacists Association 的常见问题
Journal of the American Pharmacists Association 是中科院几区期刊？
2025 年升级版分区表中，Journal of the American Pharmacists Association 为医学 4区，小类 药学 3 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Journal of the American Pharmacists Association 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 2.33，CiteScore 为 4，h-index 为 83。
Journal of the American Pharmacists Association 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）107 篇已发表文章登记的日期，投稿到接收的中位数为 101 天（四分位 77–147 天）；投稿社区反馈的平均审稿速度为6–12 周，平均录用比例反馈为“容易”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of the American Pharmacists Association 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 300 词；参考文献格式：AMA 格式。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of the American Pharmacists Association 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 43 位编委中，没有中国大陆学者；人数最多的国家是 美国（39 位）、加拿大（3 位）、约旦（1 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of the American Pharmacists Association 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of the American Pharmacists Association 被 SCIE、Scopus 收录。
Journal of the American Pharmacists Association 是开放获取期刊吗？版面费多少？
Journal of the American Pharmacists Association 为混合开放获取。选择开放获取发表时APC 约 3,230 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。